/PRNewswire/ PACT Pharma, Inc., a privately held biopharmaceutical company developing transformational personalized neoantigen-specific and off-the-shelf T.
A new form of gene therapy uses CRISPR editing to create T-cells that hunt cancer cells. Although still in its very early stages, the treatment offers hope for those suffering from untreatable cancer.